Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

West Island Makes First Delivery of General Listing to OCS

The Power Play by The Market Herald
< Previous Video {{moreVideoText}} Next Video >

Toronto, Ontario--(Newsfile Corp. - March 16, 2022) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) ("West Island" or the "Company") is pleased to announce that further to our news release of December 21, 2021, West Island subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A West Island Culture, has forwarded its first shipment of OUESTTM brand premium Montreal cannabis to the Province of Ontario. West Island has been approved for a general listing of two SKUs in Ontario. The Ontario Cannabis Store (the "OCS") has approved the listing of West Island's Platinum Cake and Grandpa's Stash strains. The first delivery was 71 kg. of Platinum Cake premium dried flower, with THC levels over 30 percent and a strong terpene profile. Delivery of Grandpa's stash is expected to begin in the spring.

West Island CEO, Boris Ziger, states, "West Island is building on the success of first entry of OUESTTM brand premium craft cannabis into Ontario, 'Sweet Demon'. Sweet Demon was a huge success - selling out in less than a month and helped secure the general listings in Canada's largest cannabis market. We are confident that Platinum Cake will be just as well received."

About West Island

West Island is a multi-faceted, innovative company in the Quebec cannabis space. Its subsidiary, RoyalMax Biotechnology Canada Inc., is a Dorval, Quebec based Health Canada Licence Holder with standard cultivation licence, standard processing, medical sales and sales licences. The Company continues to work with Yunify Natural Technologies, a Quebec based health and personal care research and innovation company to develop proprietary products for West Island including topicals and ionic mists. Through its acquisition of Trichome Treats, an award-winning chocolatier, the Company intends on introducing edibles into the West Island product mix.

For more information on West Island Brands, please visit the website at:

On behalf of the Board of Directors
Boris Ziger

Boris Ziger, CEO & Chairman

The Company's public filings are available for review at and

For further information, please contact:
Boris Ziger, CEO at:
Telephone: 416-304-9935

Disclaimer for Forward-Looking Information

Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation's filings with the Canadian securities regulators, which filings are available at

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.

To view the source version of this press release, please visit